NFKB1 and gout: These experimental results collectively demonstrate that PTGS2 functions as a key regulator in gout-associated inflammation by modulating cell survival, promoting pro-inflammatory cytokine production, and activating the NF-κB signaling pathway, providing mechanistic insights into its role in gout pathogenesis and supporting its potential as a therapeutic target.